Cisplatin (CDDP) and irinotecan (CPT-11) versus CDDP and vindesine (VDS) in advanced (stage IIIB and stage IV) non-small cell lung cancer (NSCLC). A multicenter phase III study
1999 ◽
Vol 35
◽
pp. S249-S250
◽
Keyword(s):
Stage Iv
◽
Keyword(s):
Keyword(s):
Keyword(s):
1999 ◽
Vol 19
(3)
◽
pp. 253-259
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 142
(5)
◽
pp. 1143-1151
◽
Keyword(s):